ACS
GNOM icon

Archford Capital Strategies’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Archford Capital Strategies’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,187
Closed -$281K – 358
2025
Q4 		$281K Buy
6,187
+104
+2% +$4.61K 0.03% 284
2025
Q3 		$236K Sell
6,083
-742
-11% -$26.9K 0.03% 298
2025
Q2 		$230K Sell
6,825
-1,522
-18% -$48.2K 0.03% 293
2025
Q1 		$265K Sell
8,347
-19
-0.2% -$721 0.04% 260
2024
Q4 		$325K Sell
8,366
-517
-6% -$21.7K 0.05% 222
2024
Q3 		$395K Sell
8,883
-335
-4% -$15K 0.06% 194
2024
Q2 		$385K Buy
9,218
+3,426
+59% +$143K 0.06% 195
2024
Q1 		$264K Buy
5,792
+23
+0.4% +$1.05K 0.04% 233
2023
Q4 		$267K Buy
5,769
+777
+16% +$31.7K 0.05% 218
2023
Q3 		$203K Sell
4,992
-32
-0.6% -$1.46K 0.04% 260
2023
Q2 		$246K Sell
5,024
-184
-4% -$9.2K 0.05% 254
2023
Q1 		$251K Buy
5,208
+241
+5% +$12.4K 0.05% 249
2022
Q4 		$251K Sell
4,967
-774
-13% -$39.9K 0.06% 246
2022
Q3 		$288K Sell
5,741
-169
-3% -$9.54K 0.07% 231
2022
Q2 		$289K Buy
5,910
+129
+2% +$6.54K 0.07% 232
2022
Q1 		$357K Buy
5,781
+403
+7% +$25.4K 0.08% 215
2021
Q4 		$427K Buy
+5,378
New +$452K 0.1% 207

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return
AA
Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Archford Capital Strategies's GNOM Position: Q1 2026 in Review

Archford Capital Strategies sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026, closing a stake of 6,187 shares — an estimated $281K sold.

Archford Capital Strategies first reported a position in GNOM in Q4 2021 and held it in 17 quarters. The position peaked at $427K in Q4 2021. 40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

  • Archford Capital Strategies reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
  • Archford Capital Strategies sold 6,187 Global X Genomics & Biotechnology ETF shares in Q1 2026, an estimated $281K.
  • Archford Capital Strategies first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and held it in 17 quarters.
  • Archford Capital Strategies's Global X Genomics & Biotechnology ETF position peaked at $427K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Archford Capital Strategies's 13F filing for Q1 2026, filed 15 Apr 2026.